The first phase of the EPIC project resulted in a coordinated set of immunization costing and financing studies in 2012-2014 in six countries (Benin, Ghana, Uganda, Zambia, Moldova, and Honduras). The phase 1 studies collected data at central, subnational, and facility-level and were notable for their rigor in terms of sample design and comprehensiveness of resource use measurement.
In EPIC phase 2, the team from Harvard T.H. Chan School of Public Health in coordination with an expert advisory panel carried out the work that extends the work of the individual EPIC country studies by conducting analysis of data pooled from all sites; fostering the community of practice; and assessing opportunities to improve the availability and value of immunization cost and financing information.
In the third phase, the team from Harvard built upon their previous work in the following three major aims:
Aim 1: Sustain the Community of Practice and immunizationcosting.org
Aim 2: Estimate the marginal cost of immunization program improvements
Aim 3: Advance methods for immunization costing research
The EPIC project was funded by the Bill & Melinda Gates Foundation.
